Drug Information

Drug General Information
Drug ID
D04XJT
Former ID
DNC014657
Drug Name
2-Methoxy-5-(3,4,5-trimethoxy-phenoxy)-phenol
Drug Type
Small molecular drug
Indication Discovery agent Investigative [525946]
Formula
C16H18O6
Canonical SMILES
COC1=C(C=C(C=C1)OC2=CC(=C(C(=C2)OC)OC)OC)O
InChI
1S/C16H18O6/c1-18-13-6-5-10(7-12(13)17)22-11-8-14(19-2)16(21-4)15(9-11)20-3/h5-9,17H,1-4H3
InChIKey
OJRSPUQFMNDPAN-UHFFFAOYSA-N
PubChem Compound ID
44367275
Target and Pathway
Target(s) Tubulin Target Info Inhibitor [525946]
Tubulin beta Target Info Inhibitor [525946]
KEGG Pathway Phagosome
Gap junction
Pathogenic Escherichia coli infection
NetPath Pathway FSH Signaling Pathway
TCR Signaling Pathway
EGFR1 Signaling Pathway
PANTHER Pathway Cytoskeletal regulation by Rho GTPase
Huntington disease
Reactome Regulation of PLK1 Activity at G2/M Transition
Loss of Nlp from mitotic centrosomes
Recruitment of mitotic centrosome proteins and complexes
Loss of proteins required for interphase microtubule organization?from the centrosome
Anchoring of the basal body to the plasma membrane
WikiPathways Parkin-Ubiquitin Proteasomal System pathway
Pathogenic Escherichia coli infection
Mitotic G2-G2/M phases
References
Ref 525946Bioorg Med Chem Lett. 2001 Jan 8;11(1):51-4.Antimitotic and cell growth inhibitory properties of combretastatin A-4-like ethers.
Ref 525946Bioorg Med Chem Lett. 2001 Jan 8;11(1):51-4.Antimitotic and cell growth inhibitory properties of combretastatin A-4-like ethers.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.